Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
- PMID: 35327457
- PMCID: PMC8945189
- DOI: 10.3390/biomedicines10030656
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
Abstract
In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim of our analysis was to evaluate whether Lp(a) levels could predict early vascular aging, and whether smaller apo(a) isoforms had a predictive value for vascular aging different than larger apo(a) isoforms in a cohort of subjects free from CVD. We considered the data of a subset of Brisighella Heart Study (BHS) participants free from CVD (462 men and 516 women) who were clinically evaluated during the 2012 BHS population survey. Predictors of arterial stiffness, measured as carotid-femoral pulse wave velocity (cfPWV) were estimated by the application of a step-wise linear regression model. In our cohort, there were 511 subjects with small apo(a) size and 467 subjects with large apo(a) isoforms. Subjects with larger apo(a) isoform sizes had significantly lower serum levels of Lp(a). In the BHS subpopulation sample, cfPWV was predicted by age, systolic blood pressure (SBP), serum levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and sex, higher HDL-C serum levels and female sex associated with lower values of cfPWV. In subjects with smaller apo(a) isoform sizes, predictors of cfPWV were age, SBP, sex and serum levels of HDL-C, being higher HDL-C serum levels and female sex associated to lower values of cfPWV. In subjects with larger apo(a) isoform sizes, cfPWV was predicted by age, SBP, serum levels of Lp(a) and sex, with female sex associated with lower values of cfPWV. In our subpopulation sample, Lp(a) did not predict cfPWV. However, in subjects with large apo(a) isoform sizes, Lp(a) was a significant predictor of arterial stiffness.
Keywords: Lp(a); apo(a); apolipoprotein(a); arterial stiffness; kringles; lipoprotein(a); pulse wave velocity.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization.medRxiv [Preprint]. 2024 Mar 19:2024.03.18.24304485. doi: 10.1101/2024.03.18.24304485. medRxiv. 2024. Update in: JVS Vasc Sci. 2024 Jun 11;5:100211. doi: 10.1016/j.jvssci.2024.100211. PMID: 38562737 Free PMC article. Updated. Preprint.
-
Overall and abdominal obesity indicators had different association with central arterial stiffness and hemodynamics independent of age, sex, blood pressure, glucose, and lipids in Chinese community-dwelling adults.Clin Interv Aging. 2013;8:1579-84. doi: 10.2147/CIA.S54352. Epub 2013 Nov 27. Clin Interv Aging. 2013. PMID: 24348027 Free PMC article.
-
Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).Jpn Circ J. 1999 Sep;63(9):659-65. doi: 10.1253/jcj.63.659. Jpn Circ J. 1999. PMID: 10496479
-
Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization.JVS Vasc Sci. 2024 Jun 11;5:100211. doi: 10.1016/j.jvssci.2024.100211. eCollection 2024. JVS Vasc Sci. 2024. PMID: 39101011 Free PMC article. Review.
-
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?Cardiol Ther. 2024 Mar;13(1):39-67. doi: 10.1007/s40119-024-00353-w. Epub 2024 Feb 21. Cardiol Ther. 2024. PMID: 38381282 Free PMC article. Review.
Cited by
-
Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies.Endocrine. 2023 May;80(2):292-302. doi: 10.1007/s12020-022-03287-2. Epub 2022 Dec 21. Endocrine. 2023. PMID: 36542268
-
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods.Int J Mol Sci. 2023 Sep 9;24(18):13886. doi: 10.3390/ijms241813886. Int J Mol Sci. 2023. PMID: 37762189 Free PMC article. Review.
-
Lipoprotein(a) in the Korean Pediatric Population Visiting Local Clinics and Hospitals.Nutrients. 2022 Jul 8;14(14):2820. doi: 10.3390/nu14142820. Nutrients. 2022. PMID: 35889777 Free PMC article.
-
Healthy Eating beyond Whole Grains-Insight on Associations between Diet Quality and Arterial Stiffness in the Brisighella Heart Study Cohort.Nutrients. 2024 Aug 21;16(16):2792. doi: 10.3390/nu16162792. Nutrients. 2024. PMID: 39203928 Free PMC article.
-
Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population.Front Cardiovasc Med. 2022 May 27;9:899841. doi: 10.3389/fcvm.2022.899841. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35711343 Free PMC article.
References
-
- Huang Z., Yang Y., Lu J., Liang J., He Y., Yu Y., Huang H., Li Q., Wang B., Li S., et al. Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study. Front. Cardiovasc. Med. 2021;8:747120. doi: 10.3389/fcvm.2021.747120. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous